Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesar M Castro

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Plos One|June 3, 2016
CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer PrognosisAmanda Sosulski, Heiko Horn, Lihua Zhang, et al.
Nature Communications|July 25, 2024
Empowering the on-site detection of nucleic acids by integrating CRISPR and digital signal processingChang Yeol Lee, Hyunho Kim, Ismail Degani, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2015
AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancerDavid Pépin, Amanda Sosulski, Lihua Zhang, et al.
Theranostics|December 28, 2019
Point-of-care cervical cancer screening using deep learning-based microholographyDivya Pathania, Christian Landeros, Lucas Rohrer, et al.
Scientific Reports|November 20, 2018
Deep transfer learning-based hologram classification for molecular diagnosticsSung-Jin Kim, Chuangqi Wang, Bing Zhao, et al.
ACS Nano|February 6, 2023
Dual-Enhanced Plasmonic Biosensing for Point-of-Care Sepsis DetectionLip Ket Chin, Jun-Yeong Yang, Benjamin Chousterman, et al.
Neoplasia (New York, N.Y.)|July 2, 2013
Targeting cathepsin E in pancreatic cancer by a small molecule allows in vivo detectionEdmund J Keliher, Thomas Reiner, Sarah Earley, et al.
Gynecologic Oncology|July 23, 2025
Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancerUrsula A Matulonis, Ignace Vergote, Kathleen N Moore, et al.
Analytical Cellular Pathology (Amsterdam)|May 14, 2025
Diagnostic Accuracy of Serum P16ink4A and FOX-P3 Concentrations for Detection of Cervical Lesions Among Women Attending a Cervical Cancer Clinic in Western Uganda: A Case-Control StudyFrank Ssedyabane, Nixon Niyonzima, Joseph Ngonzi, et al.
Biosensors & Bioelectronics|May 20, 2026
Self-amplifying CRISPR-based one-pot ultrasensitive testing for rapid SARS-CoV-2 and its variant detectionJayeon Song, Mikyung Kang, Baekdong Cha, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Plos One|June 3, 2016
CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer PrognosisAmanda Sosulski, Heiko Horn, Lihua Zhang, et al.
Nature Communications|July 25, 2024
Empowering the on-site detection of nucleic acids by integrating CRISPR and digital signal processingChang Yeol Lee, Hyunho Kim, Ismail Degani, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2015
AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancerDavid Pépin, Amanda Sosulski, Lihua Zhang, et al.
Theranostics|December 28, 2019
Point-of-care cervical cancer screening using deep learning-based microholographyDivya Pathania, Christian Landeros, Lucas Rohrer, et al.
Scientific Reports|November 20, 2018
Deep transfer learning-based hologram classification for molecular diagnosticsSung-Jin Kim, Chuangqi Wang, Bing Zhao, et al.
ACS Nano|February 6, 2023
Dual-Enhanced Plasmonic Biosensing for Point-of-Care Sepsis DetectionLip Ket Chin, Jun-Yeong Yang, Benjamin Chousterman, et al.
Neoplasia (New York, N.Y.)|July 2, 2013
Targeting cathepsin E in pancreatic cancer by a small molecule allows in vivo detectionEdmund J Keliher, Thomas Reiner, Sarah Earley, et al.
Gynecologic Oncology|July 23, 2025
Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancerUrsula A Matulonis, Ignace Vergote, Kathleen N Moore, et al.
Analytical Cellular Pathology (Amsterdam)|May 14, 2025
Diagnostic Accuracy of Serum P16ink4A and FOX-P3 Concentrations for Detection of Cervical Lesions Among Women Attending a Cervical Cancer Clinic in Western Uganda: A Case-Control StudyFrank Ssedyabane, Nixon Niyonzima, Joseph Ngonzi, et al.
Biosensors & Bioelectronics|May 20, 2026
Self-amplifying CRISPR-based one-pot ultrasensitive testing for rapid SARS-CoV-2 and its variant detectionJayeon Song, Mikyung Kang, Baekdong Cha, et al.
Pageof 9